The Cumberland Economic Development Corporation, in Maryland, announced that Ibex Biosciences, a private company, will establish operations in Cumberland. The tiny company reportedly has three employees and plans facilities to support up to 12 scientist and administrative positions.
Ibex is focused on developing antibody and gene therapy technologies for oncology, inflammation, autoimmune disease and retinal disease. Earlier this year the company was a finalist for Immunomic Therapeutics’s Cancer Discovery Incubator Award.
Immunomic Therapeutics is a privately-held, clinical stage biotech company focused on vaccines. It is based in Rockville, Mary. The company founded The Cancer Discovery Incubator. “It’s an opportunity for you to bring your company here inside ITI, work with our team, have a lab bench you can use with the supplies, access to equipment, to build your dream,” said Immunomic Therapeutics’ founder Bill Hearl, in a video on the incubator website.
READ FULL ARTICLE HERE
